TibaRay, a Stanford spinout focused on developing next-generation accelerator technology for FLASH radiotherapy, has launched a Regulation CF campaign on Wefunder, opening the company to individual investors. The campaign aims to fund the continued development of the company's proprietary Galactica linear accelerator, designed to enable radiation delivery hundreds of times faster than current systems.
FLASH radiotherapy is an emerging treatment modality that delivers radiation at ultra-high dose rates, potentially reducing damage to healthy tissue while maintaining tumor control. Research in recent years has shown promise, but enabling this type of treatment requires fundamentally new accelerator technology, which TibaRay is developing.
The company has raised more than $27 million to date, including over $14 million in non-dilutive federal research grants. Its intellectual property portfolio includes more than 20 issued and pending patents related to next-generation radiotherapy systems. TibaRay's Galactica linear accelerator has already been designed into Leo Cancer Care's upright radiotherapy system, marking the company's first commercial integration of its accelerator platform.
TibaRay is pursuing a phased commercialization strategy. In the near term, it generates revenue by commercializing its accelerator technology across medical and adjacent markets including imaging, security scanning, and non-destructive testing. The long-term objective is deployment of the PHASER radiotherapy system designed to enable ultrafast treatment delivery.
The Wefunder campaign allows individual investors to participate in this next phase of development. Investors can review the full opportunity, including technology details, partnerships, and development plans on the TibaRay campaign page.
This announcement is significant as it democratizes access to investment in a potentially transformative cancer treatment technology. By enabling individual investors to participate, TibaRay is not only raising capital but also building a community of supporters who have a vested interest in the success of FLASH radiotherapy. The implications of successful FLASH radiotherapy could be profound, offering faster, more effective cancer treatment with fewer side effects, potentially improving outcomes and quality of life for millions of patients worldwide.
